Long term update on toxicity and survival of a phase II trial of linac‐based stereotactic body radiation therapy for low‐intermediate risk prostate cancer.

Autor: D'Agostino, Giuseppe R., Badalamenti, Marco, Stefanini, Sara, Baldaccini, Davide, Franzese, Ciro, Faro, Lorenzo Lo, Di Cristina, Luciana, Vernier, Veronica, Reggiori, Giacomo, Scorsetti, Marta
Zdroj: Prostate; Mar2024, Vol. 84 Issue 4, p368-375, 8p
Databáze: Complementary Index
Externí odkaz: